Tag: mRNA manufacturing

Victoria’s manufacturing sector is gaining a major lift through its growing mRNA industry, with new analysis highlighting both economic and healthcare benefits for the state and the nation.

The Victorian government has established a new research and development fund to help the local industry manufacture new products, harness innovation, and compete in new global markets.

Australian contract development and manufacturing organisation (CDMO) BioCina has received an AUD 5 million grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to develop enabling technologies for the manufacture of precision mRNA vaccines.

Australian contract development and manufacturing organisation (CDMO) BioCina has appointed Mark Womack as the chief executive officer who will be responsible for the continued growth, commercial strategy and organisational culture of the company.

Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, recently announced they have entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million.

Biotech giant Moderna has begun constructing its new mRNA vaccine manufacturing facility at Monash University’s Clayton campus in Melbourne’s southeast. 

Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...

German biotechnology company BioNTech has unveiled plans to expand its global footprint to Asia with the establishment of its Regional Headquarters and a fully...